Vanguard Group
CCEL icon

Vanguard Group’s Cryo-Cell International CCEL Stock Holding History

Vanguard Group’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$519K Hold
150,991
– – ﹤0.01% 3933
2025
Q3 		$701K Buy
150,991
+21,177
+16% +$100K ﹤0.01% 3875
2025
Q2 		$674K Buy
129,814
+11,579
+10% +$61.1K ﹤0.01% 3855
2025
Q1 		$753K Buy
118,235
+1,279
+1% +$9.28K ﹤0.01% 3787
2024
Q4 		$867K Buy
116,956
+108
+0.1% +$815 ﹤0.01% 3809
2024
Q3 		$744K Buy
116,848
+2,069
+2% +$14.3K ﹤0.01% 3860
2024
Q2 		$873K Buy
114,779
+21,840
+23% +$181K ﹤0.01% 3837
2024
Q1 		$693K Buy
92,939
+1,800
+2% +$10.2K ﹤0.01% 3926
2023
Q4 		$524K Buy
91,139
+7,256
+9% +$37.6K ﹤0.01% 4021
2023
Q3 		$441K Buy
83,883
+10,095
+14% +$59.1K ﹤0.01% 4092
2023
Q2 		$449K Buy
73,788
+1,475
+2% +$7.13K ﹤0.01% 4148
2023
Q1 		$218K Hold
72,313
– – ﹤0.01% 4307
2022
Q4 		$306K Buy
72,313
+77
+0.1% +$369 ﹤0.01% 4220
2022
Q3 		$441K Hold
72,236
– – ﹤0.01% 4245
2022
Q2 		$426K Hold
72,236
– – ﹤0.01% 4326
2022
Q1 		$551K Hold
72,236
– – ﹤0.01% 4382
2021
Q4 		$838K Buy
+72,236
New +$901K ﹤0.01% 4310

Other funds holding CCEL

HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Vanguard Group's CCEL Position: Q4 2025 in Review

Vanguard Group held its Cryo-Cell International (CCEL) position steady in Q4 2025 at 150,991 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #3933.

Vanguard Group first reported a position in CCEL in Q4 2021 and has held it in 17 quarters since. The position peaked at $873K in Q2 2024. 17 funds tracked by Wall St. Rank hold CCEL as of Q4 2025.

  • Vanguard Group held 150,991 shares of Cryo-Cell International worth $519K as of Q4 2025.
  • Vanguard Group left its Cryo-Cell International share count unchanged in Q4 2025.
  • Cryo-Cell International made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3933 holding.
  • Vanguard Group first reported a position in Cryo-Cell International in Q4 2021 and has held it in 17 quarters since.
  • Vanguard Group's Cryo-Cell International position peaked at $873K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held Cryo-Cell International as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.